BRIDGEWATER, N.J., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device, a simple, all-in-one, ...
BRIDGEWATER, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device, today announced it has ...
In older adults with type 2 diabetes, use of human regular insulin delivered by V-Go ® demonstrated similar glycemic control with no increased hypoglycemia risk compared to use of rapid acting insulin ...
(ARA) - Nearly 26 million people in the United States have diabetes and the population continues to grow. There are approximately 5.5 million people in the U.S. who depend on daily insulin injections ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has cleared the Omnipod Go for use by adults ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results